Anti-ROR1 monoclonal antibodies (mAbs) and ROR1 specific RNA interference (RNAi) molecules induced apoptosis and growth impairment of several types of malignant cells expressing ROR1 including pancreatic carcinoma [12–14]. The gene discussed is ROR1; the disease is exocrine pancreatic carcinoma.